Skip to main content
ImmuneCited

Differential impact of environmental factors on systemic and localized autoimmunity.

Hanane Touil, Kristin Mounts, Philip Lawrence De Jager
Review Frontiers in immunology 2023 33 citations
PubMed DOI CC-BY PDF
<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'pmid\u003D37283765'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Study Type
Review
Intervention
Differential impact of environmental factors on systemic and localized autoimmunity. None
Comparator
Placebo
Effect Direction
Mixed
Risk of Bias
Unclear

Abstract

The influence of environmental factors on the development of autoimmune disease is being broadly investigated to better understand the multifactorial nature of autoimmune pathogenesis and to identify potential areas of intervention. Areas of particular interest include the influence of lifestyle, nutrition, and vitamin deficiencies on autoimmunity and chronic inflammation. In this review, we discuss how particular lifestyles and dietary patterns may contribute to or modulate autoimmunity. We explored this concept through a spectrum of several autoimmune diseases including Multiple Sclerosis (MS), Systemic Lupus Erythematosus (SLE) and Alopecia Areata (AA) affecting the central nervous system, whole body, and the hair follicles, respectively. A clear commonality between the autoimmune conditions of interest here is low Vitamin D, a well-researched hormone in the context of autoimmunity with pleiotropic immunomodulatory and anti-inflammatory effects. While low levels are often correlated with disease activity and progression in MS and AA, the relationship is less clear in SLE. Despite strong associations with autoimmunity, we lack conclusive evidence which elucidates its role in contributing to pathogenesis or simply as a result of chronic inflammation. In a similar vein, other vitamins impacting the development and course of these diseases are explored in this review, and overall diet and lifestyle. Recent work exploring the effects of dietary interventions on MS showed that a balanced diet was linked to improvement in clinical parameters, comorbid conditions, and overall quality of life for patients. In patients with MS, SLE and AA, certain diets and supplements are linked to lower incidence and improved symptoms. Conversely, obesity during adolescence was linked with higher incidence of MS while in SLE it was associated with organ damage. Autoimmunity is thought to emerge from the complex interplay between environmental factors and genetic background. Although the scope of this review focuses on environmental factors, it is imperative to elaborate the interaction between genetic susceptibility and environment due to the multifactorial origin of these disease. Here, we offer a comprehensive review about the influence of recent environmental and lifestyle factors on these autoimmune diseases and potential translation into therapeutic interventions.

Full Text

PDF
Loading PDF...

Figures

Tables

Table 1

Environmental factorsMultiple Sclerosis (MS)Systemic Lupus Erythematosus (SLE)Alopecia Areata (AA)
Vitamin D(Vit D)Deficient (<20ng/mL), or insufficient(21-29ng/mL) Vit D levels are reported in MS (6)Higher levels of ultraviolet B (UVB) irradiation are strongly associated with the prevalence of MS (r=-0.80, p<10-5) (7)Association between rs731236 (Taq-1) gene polymorphism within vitamin D Receptor (VDR) with MS (8)SLE genetic susceptibility (CYP24A1 gene allele) (9)Deficient Vit D levels (~21.6ng/mL) (10)Low Vit D levels as a result of sunlight avoidance due to photosensitivity/renal insufficiency (11, 12)Low serum levels of Vit D (14.03 ± 8.09 ng/mL) in AA, which represents 79.6% of patients with low Vit D compared to controls (13)Lower serum (9.99 ± 1.69 ng/mL) and tissue (199.7 ± 33.38ng/mL) Vit D receptor (VDR) in AA (14)
Obesity˜3% weight increase in MS cases (n=1571) compared to controls (n=3371) (15)Significant 1.61-1.95 fold increased risk of MS associated with higher body mass index (BMI) in a cohort of (n=302,043) children (16)Adult GWAS data (n=32,105) identified 70 distinct SNPs related to genetically high BMI as a risk to develop MS (17)Expansion of adipocytes, a source of pro-inflammatory cytokines IL-6, TNF-α, in turn, help recruit immune cell infiltrates (18, 19)High resistin levels correlate with higher BMI, EDSS and IL-1β and TNF-α (20, 21)85% significant increase risk to develop SLE in obese women compared to those with healthy BMI (22)Obesity at age 18 is associated with double SLE incidence during adulthood (HR 2.38, 95% CI:1,26-4.51) (23)Increased pro-inflammatory markers IL-6, IL-23, TNF-α & C-reactive protein (CRP) (24) known to be elevated in SLE and produced by adipose tissue.SLE patients harbor elevated serum resistin levels (p<0.001) that correlate with renal dysfunction and proinflammatory markers (25)Higher BMI (p=0.005) in a Japanese AA cohort (n=70) compared to controls (n=70) (26)Higher BMI correlates positively with alopecia disease severity in males (n=189, p=0.01) (27)Lower serum levels of adiponectin (p=0.031) and resistin (p=0.017) with AA (n=65) compared to controls (n=71) (28)Negative correlation between adiponectin serum levels and AA disease severity p<0.05 (28)
DietLow iron (p=0.04), magnesium (p<0.001) levels in MS patients (9, 29)High sodium (40nM) found in western diet promotes in vitro Th17 differentiation(30)Mediterranean diet reduces inflammation through phenols and protect CNS from oxidative stress (31)Inadequate intakes of iodine, potassium, magnesium, folate, and vitamins E and D, and overconsumption of sugar, sodium, and phosphorus (32, 33)High fiber intake by SLE patients may prevent disease activity(34)Vegetarian/pesco-vegetarian diets is associated with lower odds of SLE (35)Protein deficiency (intake <30g/day) is associated with AA disease onset (28)Deficiencies in biotin (B7) (<100ng/L) and folate (B9) (110.62-243.75 ng/mL/cells) are associated with hair loss and AA (36, 37)Iron deficiency was reported in 56% of AA patients (<40ng/mL) compared to controls (38)Beneficial role of Mediterranean diet rich in fruits, vegetables (OR 0.43; 95% CI 0.21-0.89)in AA (n=104) compared to controls (39, 40)

References

  1. Efficacy and safety of multiple sclerosis drugs approved since 2018 and future developments CNS Drugs, 2022
  2. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility Science, 2019
  3. Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus Nat Genet, 2015
  4. Genome-wide association study in alopecia areata implicates both innate and adaptive immunity Nature, 2010
  5. Epstein-Barr Virus and multiple sclerosis Nat Rev Microbiol, 2023
  6. The vitamin d deficiency pandemic: approaches for diagnosis, treatment and prevention Rev Endocr Metab Disord, 2017
  7. Association of UV radiation with multiple sclerosis prevalence and sex ratio in France Neurology, 2011
  8. Association between polymorphisms in the vitamin d receptor and susceptibility to multiple sclerosis Pharmacogenet Genomics, 2021
  9. Combined role of vitamin d status and CYP24A1 in the transition to systemic lupus erythematosus Ann Rheum Dis, 2017
  10. Vitamin d deficiency in systemic lupus erythematosus Autoimmun Rev, 2006
  11. Vitamin d may not be a good marker of disease activity in Korean patients with systemic lupus erythematosus Rheumatol Int, 2011
  12. Darkness hormone or daylight hormone in women with systemic lupus erythematosus Clin Rheumatol, 2023
  13. Serum ferritin and vitamin d levels should be evaluated in patients with diffuse hair loss prior to treatment Postepy Dermatol Alergol, 2020
  14. Assessment of vitamin d receptors in alopecia areata and androgenetic alopecia J Cosmet Dermatol, 2016
  15. High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women Mult Scler, 2012
  16. Childhood body mass index and multiple sclerosis risk: a long-term cohort study Mult Scler, 2013
  17. Obesity and multiple sclerosis: a mendelian randomization study PloS Med, 2016
  18. IL-17 in obesity and adipogenesis Cytokine Growth Factor Rev, 2010
  19. Role of immune cells in obesity induced low grade inflammation and insulin resistance Cell Immunol, 2017
  20. Obesity worsens central inflammation and disability in multiple sclerosis Mult Scler, 2020
  21. Evidences of dual role of vitamin d through cellular energy homeostasis and inflammation pathway in risk of cancer in obese subjects Minerva Med, 2013
  22. Obesity and the risk of systemic lupus erythematosus among women in the nurses' health studies Semin Arthritis Rheum, 2017
  23. A prospective study of obesity and risk of systemic lupus erythematosus (SLE) among black women Semin Arthritis Rheum, 2019
  24. Obesity is an independent contributor to functional capacity and inflammation in systemic lupus erythematosus Arthritis Rheum, 2005
  25. Resistin levels in lupus and associations with disease-specific measures, insulin resistance, and coronary calcification J Rheumatol, 2011
  26. Dietary habits in Japanese patients with alopecia areata Clin Cosmet Investig Dermatol, 2021
  27. Higher body mass index is associated with greater severity of alopecia in men with male-pattern androgenetic alopecia in Taiwan: a cross-sectional study J Am Acad Dermatol, 2014
  28. Adiponectin as a novel biomarker of disease severity in alopecia areata Sci Rep, 2021
  29. New insights on the nutrition status and antioxidant capacity in multiple sclerosis patients Nutrients, 2019
  30. Dynamic regulatory network controlling TH17 cell differentiation Nature, 2013
  31. Is Mediterranean diet associated with multiple sclerosis related symptoms and fatigue severity Nutr Neurosci, 2023
  32. Dietary intake and nutritional status in patients with systemic lupus erythematosus Endocrinol Diabetes Nutr (Engl Ed), 2018
  33. [Household food availability in Brazil: distribution and trends (1974-2003)] Rev Saude Publica, 2005
  34. Intakes of vitamin B6 and dietary fiber and clinical course of systemic lupus erythematosus: a prospective study of Japanese female patients J Epidemiol, 2011
  35. The association between dietary patterns and a doctor diagnosis of systemic lupus erythematosus: the adventist health study-2 Lupus, 2022
  36. Serum biotin levels in women complaining of hair loss Int J Trichology, 2016
  37. Evaluation of serum homocysteine, high-sensitivity CRP, and RBC folate in patients with alopecia areata Indian J Dermatol, 2014
  38. Causes of hair loss and the developments in hair rejuvenation Int J Cosmet Sci, 2002
  39. Mediterranean Diet: fresh herbs and fresh vegetables decrease the risk of androgenetic alopecia in males Arch Dermatol Res, 2018
  40. The role of diet as an adjuvant treatment in scarring and nonscarring alopecia Skin Appendage Disord, 2020
  41. Rising prevalence of multiple sclerosis worldwide: insights from the atlas of MS, third edition Mult Scler, 2020
  42. Ocrelizumab versus placebo in primary progressive multiple sclerosis N Engl J Med, 2017
  43. Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis N Engl J Med, 2017
  44. Cellular immunology of relapsing multiple sclerosis: interactions, checks, and balances Lancet Neurol, 2021
  45. Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis Nat Med, 2008
  46. Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: the MIRROR study Neurology, 2018
  47. Ofatumumab versus teriflunomide in multiple sclerosis N Engl J Med, 2020
  48. Distinct effector cytokine profiles of memory and naive human b cell subsets and implication in multiple sclerosis J Immunol, 2007
  49. Proinflammatory GM-CSF-producing b cells in multiple sclerosis and b cell depletion therapy Sci Transl Med, 2015
  50. Abnormal b-cell cytokine responses a trigger of T-cell-mediated disease in MS Ann Neurol, 2010
  51. Migration - a route to multiple sclerosis risk globalization Nat Rev Neurol, 2020
  52. Epidemiology and phenotypes of multiple sclerosis in the middle East north Africa (MENA) region Mult Scler J Exp Transl Clin, 2020
  53. Multiple sclerosis in childhood: clinical features of 149 cases Mult Scler, 1997
  54. Pediatric multiple sclerosis Curr Neurol Neurosci Rep, 2004
  55. MRI And laboratory features and the performance of international criteria in the diagnosis of multiple sclerosis in children and adolescents: a prospective cohort study Lancet Child Adolesc Health, 2018
  56. Socio-economic factors and immigrant population studies of multiple sclerosis Acta Neurol Scand, 2015
  57. MS risk in immigrants in the McDonald era: a population-based study in Ontario, Canada Neurology, 2019
  58. Gestational vitamin d and the risk of multiple sclerosis in offspring Ann Neurol, 2011
  59. Racial and ethnic differences in antibiotic use for viral illness in emergency departments Pediatrics, 2017
  60. Vitamin d status during pregnancy and risk of multiple sclerosis in offspring of women in the Finnish maternity cohort JAMA Neurol, 2016
  61. High risk of MS in Iranian immigrants in gothenburg, Sweden Mult Scler, 2010
  62. Maternal and perinatal exposures are associated with risk for pediatric-onset multiple sclerosis Pediatrics, 2017
  63. Cesarean section and offspring's risk of multiple sclerosis: a Danish nationwide cohort study Mult Scler, 2013
  64. Cesarean delivery may increase the risk of multiple sclerosis Mult Scler, 2012
  65. Month of birth as a latitude-dependent risk factor for multiple sclerosis in Norway Mult Scler, 2013
  66. Reply to comment: month of birth and risk of multiple sclerosis: confounding and adjustments Ann Clin Transl Neurol, 2014
  67. Confounding underlies the apparent month of birth effect in multiple sclerosis Ann Neurol, 2013
  68. Breastfeeding, ovulatory years, and risk of multiple sclerosis Neurology, 2017
  69. Menarche increases relapse risk in pediatric multiple sclerosis Mult Scler, 2016
  70. Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among united states military personnel Mult Scler, 2011
  71. Anti-inflammatory nutritional intervention in patients with relapsing-remitting and primary-progressive multiple sclerosis: a pilot study Exp Biol Med (Maywood), 2016
  72. The evidence for a beneficial role of vitamin a in multiple sclerosis CNS Drugs, 2014
  73. Prevention and treatment of MS: studying the effects of vitamin d Mult Scler, 2011
  74. Modulation of inflammatory and immune responses by vitamin d J Autoimmun, 2017
  75. 1,25-dihydroxyvitamin D3 inhibits IFN-gamma and IL-4 levels during in vitro polarization of primary murine CD4+ T cells J Immunol, 2002
  76. 1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells J Clin Invest, 1984
  77. Modulatory effects of 1,25-dihydroxyvitamin D3 on human b cell differentiation J Immunol, 2007
  78. VDUP1 is required for the development of natural killer cells Immunity, 2005
  79. 1alpha,25-dihydroxyvitamin D(3) mechanism of action: modulation of l-type calcium channels leading to calcium uptake and intermediate filament phosphorylation in cerebral cortex of young rats Biochim Biophys Acta, 2012
  80. 1,25-dihydroxyvitamin D3 regulates NT-3, NT-4 but not BDNF mRNA in astrocytes Neuroreport, 1994
  81. Lifestyle and environmental factors in multiple sclerosis Cold Spring Harb Perspect Med, 2019
  82. Body mass index during adolescence, rather than childhood, is critical in determining MS risk Mult Scler, 2016
  83. Evidence for a causal relationship between low vitamin d, high BMI, and pediatric-onset MS Neurology, 2017
  84. Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome Neurology, 2013
  85. Inflammation and insulin resistance J Clin Invest, 2006
  86. Obesity and multiple sclerosis-a multifaceted association J Clin Med, 2021
  87. Inflammation correlates with markers of T-cell subsets including regulatory T cells in adipose tissue from obese patients Obes (Silver Spring), 2011
  88. T-Cell profile in adipose tissue is associated with insulin resistance and systemic inflammation in humans Arterioscler Thromb Vasc Biol, 2014
  89. Obesity drives Th17 cell differentiation by inducing the lipid metabolic kinase, ACC1 Cell Rep, 2015
  90. Visceral adipose inflammation in obesity is associated with critical alterations in tregulatory cell numbers PloS One, 2011
  91. Multiple sclerosis and obesity: the role of adipokines Front Immunol, 2022
  92. Pro-inflammatory adiponectin in pediatric-onset multiple sclerosis Mult Scler, 2021
  93. Adiponectin profile at baseline is correlated to progression and severity of multiple sclerosis Eur J Neurol, 2019
  94. Correction to: adiponectin in cerebrospinal fluid from patients affected by multiple sclerosis is correlated with the progression and severity of disease Mol Neurobiol, 2021
  95. Elevated cerebrospinal fluid adiponectin and adipsin levels in patients with multiple sclerosis: a Finnish co-twin study Eur J Neurol, 2010
  96. Detection of adiponectin in cerebrospinal fluid in humans Am J Physiol Endocrinol Metab, 2007
  97. Evaluation of the relationship between leptin, resistin, adiponectin and natural regulatory T cells in relapsing-remitting multiple sclerosis Neurol Neurochir Pol, 2012
  98. Experimental and clinical studies on dysregulation of magnesium metabolism and the aetiopathogenesis of multiple sclerosis Magnes Res, 1992
  99. Current methods of magnetic resonance for noninvasive assessment of molecular aspects of pathoetiology in multiple sclerosis Int J Mol Sci, 2020
  100. Individual and Co-occurring SNAP risk factors: smoking, nutrition, alcohol consumption, and physical activity in people with multiple sclerosis Int J MS Care, 2016
  101. Review: mitochondria and disease progression in multiple sclerosis Neuropathol Appl Neurobiol, 2008
  102. Correction to: dietary interventions and multiple sclerosis Curr Neurol Neurosci Rep, 2017
  103. Western Lifestyle and immunopathology of multiple sclerosis Ann N Y Acad Sci, 2018
  104. High fat diet exacerbates neuroinflammation in an animal model of multiple sclerosis by activation of the renin angiotensin system J Neuroimmune Pharmacol, 2014
  105. A prospective study of serum levels of polyunsaturated fatty acids and effects on multiple sclerosis disease activity and progression Neurology, 2022
  106. Polyunsaturated fatty acids and the risk of multiple sclerosis Mult Scler, 2017
  107. Docosahexaenoic acid induces M2 macrophage polarization through peroxisome proliferator-activated receptor gamma activation Life Sci, 2015
  108. Unsaturated fatty acids promote the phagocytosis of p. aeruginosa and r. equi by RAW264.7 macrophages Curr Microbiol, 2012
  109. Omega-3 fatty acids decrease oxidative stress and inflammation in macrophages from patients with small abdominal aortic aneurysm Sci Rep, 2019
  110. Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses Sci Transl Med, 2016
  111. Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis J Neuroinflamm, 2011
  112. An adverse lipid profile and increased levels of adiposity significantly predict clinical course after a first demyelinating event J Neurol Neurosurg Psychiatry, 2017
  113. Saturated fatty acids activate TLR-mediated proinflammatory signaling pathways J Lipid Res, 2012
  114. TLR2 stimulation regulates the balance between regulatory T cell and Th17 function: a novel mechanism of reduced regulatory T cell function in multiple sclerosis J Immunol, 2015
  115. Toll-like receptor 4 signaling in T cells promotes autoimmune inflammation Proc Natl Acad Sci U.S.A., 2012
  116. Biological role of toll-like receptor-4 in the brain J Neuroimmunol, 2014
  117. The association of diet with quality of life, disability, and relapse rate in an international sample of people with multiple sclerosis Nutr Neurosci, 2015
  118. Contribution of dietary intake to relapse rate in early paediatric multiple sclerosis J Neurol Neurosurg Psychiatry, 2018
  119. Diet quality is associated with disability and symptom severity in multiple sclerosis Neurology, 2018
  120. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells Nature, 2013
  121. Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1 Nature, 2013
  122. Fecal microbiota transplantation is safe and tolerable in patients with multiple sclerosis: a pilot randomized controlled trial Mult Scler J Exp Transl Clin, 2022
  123. Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course Cell, 2022
  124. Dietary non-fermentable fiber prevents autoimmune neurological disease by changing gut metabolic and immune status Sci Rep, 2018
  125. Recirculating intestinal IgA-producing cells regulate neuroinflammation via IL-10 Cell, 2019
  126. Gut microbiota-specific IgA(+) b cells traffic to the CNS in active multiple sclerosis Sci Immunol, 2020
  127. 2019 European league against Rheumatism/American college of rheumatology classification criteria for systemic lupus erythematosus Arthritis Rheumatol, 2019
  128. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus Arthritis Rheum, 2012
  129. Immunological pathogenesis and treatment of systemic lupus erythematosus World J Pediatr, 2020
  130. Systemic lupus erythematosus N Engl J Med, 2011
  131. Pathogenesis of human systemic lupus erythematosus: a cellular perspective Trends Mol Med, 2017
  132. Germinal center exclusion of autoreactive b cells is defective in human systemic lupus erythematosus J Clin Invest, 2005
  133. Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions J Clin Invest, 2003
  134. A new population of cells lacking expression of CD27 represents a notable component of the b cell memory compartment in systemic lupus erythematosus J Immunol, 2007
  135. Pathogenesis of human systemic lupus erythematosus: recent advances Trends Mol Med, 2010
  136. CD19(+)CD24(hi)CD38(hi) b cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients Immunity, 2010
  137. Therapeutic potential of CD8+ cytotoxic T lymphocytes in SLE Autoimmun Rev, 2009
  138. Immunoregulatory T cells in autoimmunity Autoimmun Rev, 2004
  139. New insights into the immunopathogenesis of systemic lupus erythematosus Nat Rev Rheumatol, 2016
  140. Analysis of trans-ancestral SLE risk loci identifies unique biologic networks and drug targets in African and European ancestries Am J Hum Genet, 2020
  141. Understanding the concept of pre-clinical autoimmunity: prediction and prevention of systemic lupus erythematosus: identifying risk factors and developing strategies against disease development Front Immunol, 2022
  142. Early disease onset is predicted by a higher genetic risk for lupus and is associated with a more severe phenotype in lupus patients Ann Rheum Dis, 2011
  143. Relationship between genetic risk and age of diagnosis in systemic lupus erythematosus J Rheumatol, 2021
  144. Familial aggregation of systemic lupus erythematosus and coaggregation of autoimmune diseases in affected families JAMA Intern Med, 2015
  145. Are prematurity and environmental factors determinants for developing childhood-onset systemic lupus erythematosus Mod Rheumatol, 2018
  146. An update on the management of childhood-onset systemic lupus erythematosus Paediatr Drugs, 2021
  147. Environmental exposures and the development of systemic lupus erythematosus Curr Opin Rheumatol, 2016
  148. Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus Genome Res, 2010
  149. Epigenetic alterations underlying autoimmune diseases Autoimmunity, 2016
  150. Environmental exposures, epigenetic changes and the risk of lupus Lupus, 2014
  151. Cigarette smoking and the risk of systemic lupus erythematosus: a meta-analysis Arthritis Rheum, 2004
  152. Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation J Am Acad Dermatol, 1990
  153. Epstein-Barr Virus and systemic lupus erythematosus Clin Dev Immunol, 2012
  154. Do selected drugs increase the risk of lupus? a matched case-control study Br J Clin Pharmacol, 2010
  155. REDD1/autophagy pathway promotes thromboinflammation and fibrosis in human systemic lupus erythematosus (SLE) through NETs decorated with tissue factor (TF) and interleukin-17A (IL-17A) Ann Rheum Dis, 2019
  156. Programmed cell death pathways in the pathogenesis of systemic lupus erythematosus J Immunol Res, 2019
  157. Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease J Immunol, 2012
  158. Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus Nat Genet, 2011
  159. Complement genes contribute sex-biased vulnerability in diverse disorders Nature, 2020
  160. Environmental exposure, estrogen and two X chromosomes are required for disease development in an epigenetic model of lupus J Autoimmun, 2012
  161. Immunomodulatory effects of synthetic endocrine disrupting chemicals on the development and functions of human immune cells Environ Int, 2019
  162. Increased occurrence of autoimmune disease among women exposed in utero to diethylstilbestrol Fertil Steril, 1988
  163. Early life factors associated with adult-onset systemic lupus erythematosus in women Front Immunol, 2016
  164. Insecticide use and risk of rheumatoid arthritis and systemic lupus erythematosus in the women's health initiative observational study Arthritis Care Res (Hoboken), 2011
  165. Occupational risk factors for the development of systemic lupus erythematosus J Rheumatol, 2004
  166. Pesticides and human chronic diseases: evidences, mechanisms, and perspectives Toxicol Appl Pharmacol, 2013
  167. Pesticides and oxidative stress: a review Med Sci Monit, 2004
  168. Systemic autoimmune disease mortality and occupational exposures Arthritis Rheum, 2007
  169. Vitamin d deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences Rheumatol (Oxford), 2008
  170. Vitamin d deficiency in patients with active systemic lupus erythematosus Osteoporos Int, 2009
  171. The implication of vitamin d and autoimmunity: a comprehensive review Clin Rev Allergy Immunol, 2013
  172. Vitamin d receptor gene BsmI polymorphism b allele, but not BB genotype, is associated with systemic lupus erythematosus in a han Chinese population Lupus, 2012
  173. No association of vitamin d receptor gene start codon fok 1 polymorphisms in Chinese patients with systemic lupus erythematosus J Rheumatol, 2002
  174. The role of BsmI and FokI vitamin d receptor gene polymorphisms and serum 25-hydroxyvitamin d in Brazilian patients with systemic lupus erythematosus Lupus, 2012
  175. Vitamin d prevents endothelial damage induced by increased neutrophil extracellular traps formation in patients with systemic lupus erythematosus Acta Med Indones, 2014
  176. Restoration of regulatory and effector T cell balance and b cell homeostasis in systemic lupus erythematosus patients through vitamin d supplementation Arthritis Res Ther, 2012
  177. Nutritional status and food intake in patients with systemic lupus erythematosus Nutrition, 2012
  178. The impact of obesity on SLE disease activity: findings from the southern California lupus registry (SCOLR) Clin Rheumatol, 2019
  179. Separating the effects of childhood and adult body size on inflammatory arthritis: a mendelian randomisation study RMD Open, 2022
  180. Relationship of cigarette smoking and alcohol consumption to incidence of systemic lupus erythematosus in a prospective cohort study of black women Arthritis Care Res (Hoboken), 2019
  181. Serum interleukin-23 in polish patients with systemic lupus erythematosus: association with lupus nephritis, obesity, and peripheral vascular disease Mediators Inflammation, 2017
  182. Obesity and cytokines in childhood-onset systemic lupus erythematosus J Immunol Res, 2014
  183. Adiponectin in autoimmune diseases Curr Med Chem, 2012
  184. Serum adiponectin levels in patients with systemic lupus erythematosus: a meta-analysis J Clin Rheumatol, 2017
  185. Association of plasma soluble e-selectin and adiponectin with carotid plaque in patients with systemic lupus erythematosus Atherosclerosis, 2010
  186. Elevated adiponectin serum levels in women with systemic autoimmune diseases Mediators Inflammation, 2010
  187. Inflammatory biomarkers and oxidative stress measurements in patients with systemic lupus erythematosus with or without metabolic syndrome Lupus, 2011
  188. Obesity is independently associated with worse patient-reported outcomes in women with systemic lupus erythematosus Arthritis Care Res (Hoboken), 2019
  189. Obesity increases the incidence of new-onset lupus nephritis and organ damage during follow-up in patients with systemic lupus erythematosus Lupus, 2020
  190. Relationship of excess weight with clinical activity and dietary intake deficiencies in systemic lupus erythematosus patients Nutrients, 2019
  191. Obesity in autoimmune diseases: not a passive bystander Autoimmun Rev, 2014
  192. Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease Nutrients, 2012
  193. Lifestyle interventions and weight management in systemic lupus erythematosus patients: a systematic literature review and metanalysis J Lifestyle Med, 2022
  194. Weight loss and improvements in fatigue in systemic lupus erythematosus: a controlled trial of a low glycaemic index diet versus a calorie restricted diet in patients treated with corticosteroids Lupus, 2012
  195. Regular tai chi chuan exercise enhances functional mobility and CD4CD25 regulatory T cells Br J Sports Med, 2006
  196. The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease Nat Rev Immunol, 2011
  197. Sedentary behavior and adiposity-associated inflammation: the multi-ethnic study of atherosclerosis Am J Prev Med, 2012
  198. Physical activity, sedentary behaviour and their associations with cardiovascular risk in systemic lupus erythematosus Rheumatol (Oxford), 2020
  199. Three year followup of bone mineral density change in premenopausal women with systemic lupus erythematosus J Rheumatol, 1999
  200. Exercise therapy in patients with idiopathic inflammatory myopathies and systemic lupus erythematosus - a systematic literature review Best Pract Res Clin Rheumatol, 2020
  201. Novel paradigms in systemic lupus erythematosus Lancet, 2019
  202. Immunomodulatory effects of diet and nutrients in systemic lupus erythematosus (SLE): a systematic review Front Immunol, 2020
  203. Dietary intervention and health in patients with systemic lupus erythematosus: a systematic review of the evidence Crit Rev Food Sci Nutr, 2019
  204. Association of a combination of healthy lifestyle behaviors with reduced risk of incident systemic lupus erythematosus Arthritis Rheumatol, 2022
  205. Diet-quality scores and plasma concentrations of markers of inflammation and endothelial dysfunction Am J Clin Nutr, 2005
  206. Beneficial effect of Mediterranean diet on disease activity and cardiovascular risk in systemic lupus erythematosus patients: a cross-sectional study Rheumatol (Oxford), 2021
  207. Nutrition and immune system: from the Mediterranean diet to dietary supplementary through the microbiota Crit Rev Food Sci Nutr, 2021
  208. The impact of dietary fiber on gut microbiota in host health and disease Cell Host Microbe, 2018
  209. The impact of Western diet and nutrients on the microbiota and immune response at mucosal interfaces Front Immunol, 2017
  210. Gut microbial metabolites fuel host antibody responses Cell Host Microbe, 2016
  211. Dietary patterns differently associate with inflammation and gut microbiota in overweight and obese subjects PloS One, 2014
  212. Intestinal dysbiosis is associated with altered short-chain fatty acids and serum-free fatty acids in systemic lupus erythematosus Front Immunol, 2017
  213. Antioxidants in vegan diet and rheumatic disorders Toxicology, 2000
  214. Effects of eating an uncooked vegetable diet for 1 week Appetite, 1992
  215. [The role of balanced low-protein diet in inhibition of predialysis chronic kidney disease progression in patients with systemic diseases] Ter Arkh, 2009
  216. Inadequate dietary intake of children and adolescents with juvenile idiopathic arthritis and systemic lupus erythematosus J Pediatr (Rio J), 2009
  217. mTOR signaling in T cell immunity and autoimmunity Int Rev Immunol, 2015
  218. Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus Arthritis Rheum, 2002
  219. Association between T lymphocyte sub-sets apoptosis and peripheral blood mononuclear cells oxidative stress in systemic lupus erythematosus Free Radic Res, 2011
  220. Healthy lifestyle habits for patients with systemic lupus erythematosus: a systemic review Semin Arthritis Rheum, 2016
  221. Comparative effects of n-3, n-6 and n-9 unsaturated fatty acid-rich diet consumption on lupus nephritis, autoantibody production and CD4+ T cell-related gene responses in the autoimmune NZBWF1 mouse PloS One, 2014
  222. Food uses and health effects of corn oil J Am Coll Nutr, 1990
  223. Dietary fish oil and the severity of symptoms in patients with systemic lupus erythematosus Ann Rheum Dis, 1991
  224. A randomised interventional trial of omega-3-polyunsaturated fatty acids on endothelial function and disease activity in systemic lupus erythematosus Ann Rheum Dis, 2008
  225. Seluang fish (Rasbora spp.) oil decreases inflammatory cytokines via increasing vitamin d level in systemic lupus erythematosus Open Access Maced J Med Sci, 2019
  226. Placebo-controlled randomized clinical trial of fish oil's impact on fatigue, quality of life, and disease activity in systemic lupus erythematosus Nutr J, 2015
  227. The phenolic fraction of extra virgin olive oil modulates the activation and the inflammatory response of T cells from patients with systemic lupus erythematosus and healthy donors Mol Nutr Food Res, 2017
  228. Lycopene reduces mortality in people with systemic lupus erythematosus: a pilot study based on the third national health and nutrition examination survey J Dermatolog Treat, 2016
  229. Apigenin, a dietary flavonoid, sensitizes human T cells for activation-induced cell death by inhibiting PKB/Akt and NF-kappaB activation pathway Immunol Lett, 2008
  230. Effects of vitamins c and e on oxidative stress markers and endothelial function in patients with systemic lupus erythematosus: a double blind, placebo controlled pilot study J Rheumatol, 2005
  231. Serum concentrations of alpha tocopherol, beta carotene, and retinol preceding the diagnosis of rheumatoid arthritis and systemic lupus erythematosus Ann Rheum Dis, 1997
  232. Diet and systemic lupus erythematosus: a 4 year prospective study of Japanese patients J Rheumatol, 2003
  233. Serum cobalamin and transcobalamin levels in systemic lupus erythematosus Am J Med, 1990
  234. Nutritional aspects and possible pathological mechanisms of hyperhomocysteinaemia: an independent risk factor for vascular disease Proc Nutr Soc, 2000
  235. Effects of folic acid and combinations of folic acid and vitamin b-12 on plasma homocysteine concentrations in healthy, young women Am J Clin Nutr, 1998
  236. Selected vitamins and trace elements support immune function by strengthening epithelial barriers and cellular and humoral immune responses Br J Nutr, 2007
  237. Serum total homocysteine concentrations in the third national health and nutrition examination survey (1991-1994): population reference ranges and contribution of vitamin status to high serum concentrations Ann Intern Med, 1999
  238. Dietary micronutrient intake and atherosclerosis in systemic lupus erythematosus Lupus, 2016
  239. Retinoic acid and immune homeostasis: a balancing act Trends Immunol, 2017
  240. Vitamin a deficiency alters splenic dendritic cell subsets and increases CD8(+)Gr-1(+) memory T lymphocytes in C57BL/6J mice Cell Immunol, 2010
  241. Role of vitamin a in the immune system J Clin Med, 2018
  242. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid Science, 2007
  243. Vitamin a improve Th17 and treg regulation in systemic lupus erythematosus Clin Rheumatol, 2016
  244. Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus Arthritis Res Ther, 2010
  245. Effector T-cell subsets in systemic lupus erythematosus: update focusing on Th17 cells Curr Opin Rheumatol, 2011
  246. The role of dietary sodium intake on the modulation of T helper 17 cells and regulatory T cells in patients with rheumatoid arthritis and systemic lupus erythematosus PloS One, 2017
  247. Dietary sodium, potassium, and sodium to potassium ratio in patients with systemic lupus erythematosus Biol Res Nurs, 2022
  248. Intestinal dysbiosis associated with systemic lupus erythematosus mBio, 2014
  249. Translocation of a gut pathobiont drives autoimmunity in mice and humans Science, 2018
  250. Nature of T cell epitopes in lupus antigens and HLA-DR determines autoantibody initiation and diversification Ann Rheum Dis, 2019
  251. Gut microbiota dysbiosis and altered tryptophan catabolism contribute to autoimmunity in lupus-susceptible mice Sci Transl Med, 2020
  252. Portrait of an immunoregulatory bifidobacterium Gut Microbes, 2012
  253. Adaptive immune education by gut microbiota antigens Immunology, 2018
  254. Molecular mimicry and auto-immunity Clin Rev Allergy Immunol, 2007
  255. The role of bacterial DNA in autoantibody induction Curr Top Microbiol Immunol, 2000
  256. Anti-DNA meets NMDA in neuropsychiatric lupus Nat Med, 2001
  257. Gut microbiota in systemic lupus erythematosus and correlation with diet and clinical manifestations Front Med (Lausanne), 2022
  258. Phytonutrient diet supplementation promotes beneficial clostridia species and intestinal mucus secretion resulting in protection against enteric infection Sci Rep, 2015
  259. A diet-sensitive commensal lactobacillus strain mediates TLR7-dependent systemic autoimmunity Cell Host Microbe, 2019
  260. Amelioration of regulatory T cells by lactobacillus delbrueckii and lactobacillus rhamnosus in pristane-induced lupus mice model J Cell Physiol, 2019
  261. Control of lupus nephritis by changes of gut microbiota Microbiome, 2017
  262. Alopecia areata: a review of disease pathogenesis Br J Dermatol, 2018
  263. The hair follicle and immune privilege J Investig Dermatol Symp Proc, 2003
  264. Alopecia areata update: part II. treatment J Am Acad Dermatol, 2010
  265. Alopecia areata: an update on etiopathogenesis, diagnosis, and management Clin Rev Allergy Immunol, 2021
  266. Alopecia areata Nat Rev Dis Primers, 2017
  267. Functional interpretation of genome-wide association study evidence in alopecia areata J Invest Dermatol, 2016
  268. Hair follicle immune privilege and its collapse in alopecia areata Exp Dermatol, 2020
  269. Increased blood levels of NKG2D(+)CD4(+) T cells in patients with alopecia areata J Am Acad Dermatol, 2017
  270. Transcriptional profiling in alopecia areata defines immune and cell cycle control related genes within disease-specific signatures Genomics, 2010
  271. CXCR3 blockade inhibits T cell migration into the skin and prevents development of alopecia areata J Immunol, 2016
  272. Direct immunofluorescence studies in alopecia areata and male pattern alopecia J Invest Dermatol, 1979
  273. Characterization of hair follicle antigens targeted by the anti-hair follicle immune response J Investig Dermatol Symp Proc, 2003
  274. Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb Yale J Biol Med, 1993
  275. Treatment of pediatric alopecia areata: a systematic review J Am Acad Dermatol, 2022
  276. Alopecia areata. an evaluation of 736 patients Arch Dermatol, 1963
  277. Epidemiology and burden of alopecia areata: a systematic review Clin Cosmet Investig Dermatol, 2015
  278. Advances in the management of alopecia areata J Dermatol, 2012
  279. Alopecia areata N Engl J Med, 2012
  280. T-Helper and regulatory T-cell cytokines in the peripheral blood of patients with active alopecia areata Br J Dermatol, 2013
  281. Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing J Allergy Clin Immunol, 2015
  282. Oxidatively modified autoantigens in autoimmune diseases Free Radic Biol Med, 2006
  283. Morphological analysis of hair follicles in alopecia areata Microsc Res Tech, 1997
  284. Investigation of oxidative stress in patients with alopecia areata and its relationship with disease severity, duration, recurrence and pattern Clin Exp Dermatol, 2015
  285. Does oxidative stress correlate with disease activity and severity in alopecia areata? an analytical study J Cosmet Dermatol, 2022
  286. Oxidative stress biomarkers and adenosine deaminase over the alopecic area of the patients with alopecia areata Balkan Med J, 2016
  287. Oxidative stress in alopecia areata: a systematic review and meta-analysis Int J Dermatol, 2020
  288. Reversible alopecia associated with high blood mercury levels and early menopause: a report of two cases Menopause, 2019
  289. Alopecia areata and toxic metals Skin Appendage Disord, 2020
  290. Big data reveal insights into alopecia areata comorbidities J Investig Dermatol Symp Proc, 2018
  291. [Clinical case of a combination of ulcerative colitis and alopecia areata] Eksp Klin Gastroenterol, 2013
  292. Analysis of the gut microbiota in alopecia areata: identification of bacterial biomarkers J Eur Acad Dermatol Venereol, 2020
  293. Hair growth in two alopecia patients after fecal microbiota transplant ACG Case Rep J, 2017
  294. Alopecia areata as a model for T cell-dependent autoimmune diseases Exp Dermatol, 2012
  295. Lack of the vitamin d receptor is associated with reduced epidermal differentiation and hair follicle growth J Invest Dermatol, 2002
  296. The vitamin d receptor and the syndrome of hereditary 1,25-dihydroxyvitamin d-resistant rickets Endocr Rev, 1999
  297. A familial syndrome of decrease in sensitivity to 1,25-dihydroxyvitamin d J Clin Endocrinol Metab, 1978
  298. Topical calcipotriol therapy for mild-to-Moderate alopecia areata: a retrospective study J Drugs Dermatol, 2015
  299. Vitamin d receptor gene polymorphism in chronic telogen effluvium; a case-control study Clin Cosmet Investig Dermatol, 2019
  300. Vitamin d deficiency in alopecia areata Br J Dermatol, 2014
  301. An investigation of vitamin d status in alopecia areata Clin Exp Med, 2018
  302. Obesity accelerates hair thinning by stem cell-centric converging mechanisms Nature, 2021
  303. Coeliac disease and alopecia areata in childhood J Paediatr Child Health, 2003
  304. Alopecia and coeliac disease: report of two patients showing response to gluten-free diet Clin Exp Dermatol, 1998
  305. Dietary protein deficit and deregulated autophagy: a new clinico-diagnostic perspective in pathogenesis of early aging, skin, and hair disorders Indian Dermatol Online J, 2019
  306. Hair growth and alopecia in hypothyroidism Arch Dermatol, 1972
  307. The role of micronutrients in alopecia areata: a review Am J Clin Dermatol, 2017
  308. Dietary soy oil content and soy-derived phytoestrogen genistein increase resistance to alopecia areata onset in C3H/HeJ mice Exp Dermatol, 2003
  309. Alopecia areata: a multifactorial autoimmune condition J Autoimmun, 2019
  310. Administration of capsaicin and isoflavone promotes hair growth by increasing insulin-like growth factor-I production in mice and in humans with alopecia Growth Horm IGF Res, 2007
  311. Soyfoods, soybean isoflavones, and bone health: a brief overview J Ren Nutr, 2000
  312. Oxidative stress and alopecia areata J Med Life, 2015
  313. Decreased serum ferritin is associated with alopecia in women J Invest Dermatol, 2003
  314. Methylenetetrahydrofolate reductase C677T mutation in patients with alopecia areata in Turkish population Gene, 2013
  315. The variant methylenetetrahydrofolate reductase c.1298A>C (p.E429A) is associated with multiple sclerosis in a German case-control study Neurosci Lett, 2010
  316. MTHFR polymorphisms (rs1801133) and systemic lupus erythematosus risk: a meta-analysis Med (Baltimore), 2020
  317. Hair changes due to zinc deficiency in a case of sucrose malabsorption Acta Derm Venereol, 1981
  318. The diagnosis and treatment of iron deficiency and its potential relationship to hair loss J Am Acad Dermatol, 2006
  319. Does tissue iron status have a role in female alopecia J Eur Acad Dermatol Venereol, 1999
  320. A study of the tissue iron status of patients with alopecia areata Br J Dermatol, 1994
  321. The importance of adequate serum ferritin levels during oral cyproterone acetate and ethinyl oestradiol treatment of diffuse androgen-dependent alopecia in women Clin Endocrinol (Oxf), 1992
  322. Vitamin a as a regulator of antigen presenting cells J Nutr, 2010
  323. Intracellular signaling by 14-hydroxy-4,14-retro-retinol Science, 1991
  324. Retinoids regulate survival and antigen presentation by immature dendritic cells J Exp Med, 2003
  325. Vitamin a is a key regulator for cell growth, cytokine production, and differentiation in normal b cells J Biol Chem, 1992
  326. Antioxidants and lipid peroxidation status in the blood of patients with alopecia Cell Biochem Funct, 2000
  327. Retinol esterification by DGAT1 is essential for retinoid homeostasis in murine skin J Biol Chem, 2009
  328. Endogenous retinoids in the pathogenesis of alopecia areata J Invest Dermatol, 2013
  329. Understanding the gut microbiota in pediatric patients with alopecia areata and their siblings: a pilot study JID Innov, 2021
  330. Alopecia areata and the gut-the link opens up for novel therapeutic interventions Expert Opin Ther Targets, 2018
  331. Changes in intestinal tight junction permeability associated with industrial food additives explain the rising incidence of autoimmune disease Autoimmun Rev, 2015
  332. Chronic exposure to a trichloroethylene metabolite in autoimmune-prone MRL+/+ mice promotes immune modulation and alopecia Toxicol Sci, 2007
  333. Ultra-processed food consumption and exposure to phthalates and bisphenols in the US national health and nutrition examination survey, 2013-2014 Environ Int, 2019
  334. Genome-wide association meta-analysis in Chinese and European individuals identifies ten new loci associated with systemic lupus erythematosus Nat Genet, 2016
  335. Identification of 38 novel loci for systemic lupus erythematosus and genetic heterogeneity between ancestral groups Nat Commun, 2021
  336. Progressive ventricular enlargement in patients with clinically isolated syndromes is associated with the early development of multiple sclerosis J Neurol Neurosurg Psychiatry, 2002
  337. Risk factors for ANA positivity in healthy persons Arthritis Res Ther, 2011
  338. Prevalence and sociodemographic correlates of antinuclear antibodies in the united states Arthritis Rheum, 2012
  339. Familial implications of autoimmune disease: recurrence risks of alopecia areata and associated conditions in first-degree relatives J Genet Couns, 2020
  340. Genetic factors predisposing to systemic lupus erythematosus and lupus nephritis Semin Nephrol, 2010
  341. Association between immediate initiation of intramuscular interferon beta-1a at the time of a clinically isolated syndrome and long-term outcomes: a 10-year follow-up of the controlled high-risk avonex multiple sclerosis prevention study in ongoing neurological surveillance Arch Neurol, 2012
  342. Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score Lancet Neurol, 2009
  343. Assessment of early evidence of multiple sclerosis in a prospective study of asymptomatic high-risk family members JAMA Neurol, 2017
  344. Genes and environment in multiple sclerosis project: a platform to investigate multiple sclerosis risk Ann Neurol, 2016
  345. Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY) Diabetologia, 1996
  346. Screening characteristics for enrichment of individuals at higher risk for transitioning to classified SLE Lupus, 2019
  347. Risk prediction models for incident systemic lupus erythematosus among women in the nurses' health study cohorts using genetics, family history, and lifestyle and environmental factors Semin Arthritis Rheum, 2023
  348. Discerning risk of disease transition in relatives of systemic lupus erythematosus patients utilizing soluble mediators and clinical features Arthritis Rheumatol, 2017
  349. Interactions between genome-wide genetic factors and smoking influencing risk of systemic lupus erythematosus Arthritis Rheumatol, 2020
  350. Vitamin d and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial BMJ, 2022
  351. Vitamin d as an early predictor of multiple sclerosis activity and progression JAMA Neurol, 2014
  352. Vitamin d supplementation in multiple sclerosis: a critical analysis of potentials and threats Nutrients, 2020
  353. Vitamin d supplementation in adolescents and young adults with juvenile systemic lupus erythematosus for improvement in disease activity and fatigue scores: a randomized, double-blind, placebo-controlled trial Arthritis Care Res (Hoboken), 2016
  354. Vitamin d supplementation and disease activity in patients with immune-mediated rheumatic diseases: a systematic review and meta-analysis Med (Baltimore), 2017
  355. Fatigue, muscle strength and vitamin d status in women with systemic lupus erythematosus compared with healthy controls Lupus, 2012
  356. Changes in vitamin d levels in patients with systemic lupus erythematosus: effects on fatigue, disease activity, and damage Arthritis Care Res (Hoboken), 2010
  357. Real-world data on vitamin d supplementation and its impacts in systemic lupus erythematosus: cross-sectional analysis of a lupus registry of nationwide institutions (LUNA) PloS One, 2022
  358. Vitamin d supplementation in systemic lupus erythematosus: relationship to disease activity, fatigue and the interferon signature gene expression BMC Rheumatol, 2021
  359. Effects of vitamin d on systemic lupus erythematosus disease activity and autoimmunity: a systematic review and meta-analysis Cureus, 2022
  360. Comparative study of efficacy of topical mometasone with calcipotriol versus mometasone alone in the treatment of alopecia areata Int J Trichology, 2019
  361. Efficacy and safety of topical calcipotriol 0.005% versus topical clobetasol 0.05% in the management of alopecia areata: an intrasubject pilot study Dermatol Ther (Heidelb), 2020
  362. Efficacy and safety of topical calcipotriol in management of alopecia areata: a pilot study Dermatol Ther, 2017
  363. Polyunsaturated fatty acids and their potential therapeutic role in multiple sclerosis Nat Clin Pract Neurol, 2009
  364. The efficacy of vitamin e against oxidative damage and autoantibody production in systemic lupus erythematosus: a preliminary study Clin Rheumatol, 2007
  365. Abd-Allah fooda , samia El-dardiry , ayman wagih, omnia el-deeb, effect of nigella sativa and vitamin e on some oxidative / nitrosative biomarkers in systemic lupus erythematosus patients Life Sci J, 2015
  366. Vitamin e administration erases an enhanced oxidation in multiple sclerosis Can J Physiol Pharmacol, 2018
  367. Successful treatment with retinoids in patients with lupus nephritis Am J Kidney Dis, 2010
  368. Effect of vitamin a treatment on the immune reactivity of patients with systemic lupus erythematosus J Clin Lab Immunol, 1988
  369. Effect of vitamin a supplementation on fatigue and depression in multiple sclerosis patients: a double-blind placebo-controlled clinical trial Iran J Allergy Asthma Immunol, 2016
  370. Retinyl palmitate supplementation modulates T-bet and interferon gamma gene expression in multiple sclerosis patients J Mol Neurosci, 2016
  371. Phase I/II randomized bilateral half-head comparison of topical bexarotene 1% gel for alopecia areata J Am Acad Dermatol, 2009
  372. High dose thiamine improves fatigue in multiple sclerosis BMJ Case Rep, 2013
  373. Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial Lancet Neurol, 2020
  374. Zinc aspartate, biotin, and clobetasol propionate in the treatment of alopecia areata in childhood Pediatr Dermatol, 1999
  375. Zinc sulphate: a reasonable choice for depression management in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled clinical trial Pharmacol Rep, 2015
  376. Combination therapy with zinc gluconate and PUVA for alopecia areata totalis: an adjunctive but crucial role of zinc supplementation Dermatol Ther, 2015
  377. The therapeutic effect and the changed serum zinc level after zinc supplementation in alopecia areata patients who had a low serum zinc level Ann Dermatol, 2009
  378. Oral zinc sulphate in alopacia areata-a double blind trial Br J Dermatol, 1981
  379. Diet and lupus Lupus, 2001
  380. Glutathione and glutathione analogues; therapeutic potentials Biochim Biophys Acta, 2013
  381. N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial Arthritis Rheum, 2012
  382. Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus J Immunol, 2007
  383. Quantification of regulatory T cells in patients with systemic lupus erythematosus J Autoimmun, 2003
  384. Comprehensive metabolome analyses reveal n-acetylcysteine-responsive accumulation of kynurenine in systemic lupus erythematosus: implications for activation of the mechanistic target of rapamycin Metabolomics, 2015
  385. Early-stage lupus nephritis treated with n-acetylcysteine: a report of two cases Exp Ther Med, 2015
  386. N-acetyl cysteine as a neuroprotective agent in progressive multiple sclerosis (NACPMS) trial: study protocol for a randomized, double-blind, placebo-controlled add-on phase 2 trial Contemp Clin Trials, 2022
  387. N-acetyl cysteine administration affects cerebral blood flow as measured by arterial spin labeling MRI in patients with multiple sclerosis Heliyon, 2021
  388. Glutathione in multiple sclerosis: more than just an antioxidant Mult Scler, 2014
  389. Onion juice (Allium cepa l.), a new topical treatment for alopecia areata J Dermatol, 2002
  390. Allium vegetables and organosulfur compounds: do they help prevent cancer Environ Health Perspect, 2001
  391. Consumption of Brussels sprouts results in elevated alpha-class glutathione s-transferase levels in human blood plasma Carcinogenesis, 1994
  392. Glutathione s-transferase polymorphisms, cruciferous vegetable intake and cancer risk in the central and Eastern European kidney cancer study Carcinogenesis, 2007
  393. Broccoli sprouts reduce oxidative stress in type 2 diabetes: a randomized double-blind clinical trial Eur J Clin Nutr, 2011
  394. "Curcumin, the king of spices": epigenetic regulatory mechanisms in the prevention of cancer, neurological, and inflammatory diseases Curr Pharmacol Rep, 2015
  395. Treatment of low doses curcumin could modulate Th17/Treg balance specifically on CD4+ T cell cultures of systemic lupus erythematosus patients Cent Eur J Immunol, 2015
  396. Oral supplementation of turmeric decreases proteinuria, hematuria, and systolic blood pressure in patients suffering from relapsing or refractory lupus nephritis: a randomized and placebo-controlled study J Ren Nutr, 2012
  397. Nanocurcumin is a potential novel therapy for multiple sclerosis by influencing inflammatory mediators Pharmacol Rep, 2018
  398. Changes in Th17 cells function after nanocurcumin use to treat multiple sclerosis Int Immunopharmacol, 2018
  399. Nanocurcumin improves regulatory T-cell frequency and function in patients with multiple sclerosis J Neuroimmunol, 2019
  400. Efficacy of a mixed preparation containing piperine, capsaicin and curcumin in the treatment of alopecia areata J Cosmet Dermatol, 2022
  401. Nutritional control of reproductive status in honeybees via DNA methylation Science, 2008
  402. Effects of royal jelly supplementation on regulatory T cells in children with SLE Food Nutr Res, 2016
  403. Dietary interventions for multiple sclerosis Cochrane Database Syst Rev, 2012
  404. Food synergy: an operational concept for understanding nutrition Am J Clin Nutr, 2009
  405. Randomized control trial evaluation of a modified paleolithic dietary intervention in the treatment of relapsing-remitting multiple sclerosis: a pilot study Degener Neurol Neuromuscul Dis, 2017
  406. Untitled Mediterranean Vs. high-Fermented-Food diet adherence on inflammation and disease activity in systemic lupus erythematosus, 2022
  407. Combined diet and supplementation therapy resolves alopecia areata in a paediatric patient: a case study Cureus, 2020
  408. Genes and diet in the prevention of chronic diseases in future generations Int J Mol Sci, 2020
  409. The DNA methylation signature of human TCRalphabeta+CD4-CD8- double negative T cells reveals CG demethylation and a unique epigenetic architecture permissive to a broad stimulatory immune response Clin Immunol, 2015
  410. Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation J Immunol, 2009
  411. Abnormal epigenetic modifications in peripheral blood mononuclear cells from patients with alopecia areata Br J Dermatol, 2012
  412. Specific hypomethylation programs underpin b cell activation in early multiple sclerosis Proc Natl Acad Sci U.S.A., 2021
  413. Proximal and distal effects of genetic susceptibility to multiple sclerosis on the T cell epigenome Nat Commun, 2021
  414. Oxidative stress and dietary micronutrient deficiencies contribute to overexpression of epigenetically regulated genes by lupus T cells Clin Immunol, 2018
  415. Metabolic disturbances associated with systemic lupus erythematosus PloS One, 2012
  416. Changes in methionine metabolism and histone H3 trimethylation are linked to mitochondrial defects in multiple sclerosis J Neurosci, 2015
  417. Dysregulation of methionine metabolism in multiple sclerosis Neurochem Int, 2018
  418. LC-MS/MS identification of the one-carbon cycle metabolites in human plasma Electrophoresis, 2013
  419. Diet rapidly and reproducibly alters the human gut microbiome Nature, 2014
  420. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis Science, 2022
  421. Role of "Western diet" in inflammatory autoimmune diseases Curr Allergy Asthma Rep, 2014
  422. ImmVar project: insights and design considerations for future studies of "healthy" immune variation Semin Immunol, 2015

Used In Evidence Reviews

Similar Papers